Request for Assistance

Policies

• We are willing to help investigators who are Rogel Cancer Center members on their cancer related research.
• The investigator requesting assistance should explain the project using the form below. The CDS-SR leadership will then assign an appropriate member to work with them.
• For longer term assistance and collaboration the investigator is expected to write a statistician/analyst into their grant application or provide salary support through other means. CDS-SR personnel contributing to various projects are expected to be listed as co-authors on any publications resulting from their work
• The investigator requesting assistance should contact the CDS-SR well in advance of any deadline. Recommended timelines that would significantly facilitate our planning process are 
  • Advance notice of 1 month towards meeting abstracts
  • 2-3 months towards manuscripts (biostatistical/bioinformatics analysis, figure preparation etc.)
  • 3-6 months for R01 submissions
  • 6-9 months for program projects (eg SPOREs, P01s)

---

Project Intake Form

If you see this don't fill out this input box.

Name*

Email Address*

Phone Number*

Principal Investigator*

Departmental Affiliation*

Cancer Research Program Affiliation

Cancer Epidemiology & Prevention

Health Behavior & Outcomes

Translational & Clinical Research

Cancer Hematopoiesis & Immunology

Cancer Genetics Research

Cancer Biology

Developmental Therapeutics

Other

If "other" selected above, please list here

Details of project

Type of Project (Please select best fit from provided choices)

Biostatistical Analyses

Bioinformatics Analyses (sequencing/molecular data)

Clinical Trial

Study Design

other (e.g: mutation detection, CyTOF, microbiome, image analysis)

Additional information on selection above

Brief Description of Project (Aims and Scope)*

Funding source(s)

Is this for a paper or a grant?

Paper

Grant

What is the expected timeline / due date of the project?

Additional Details

Provide the statistical analysis plan, if available

Experimental Approach

Treatment Groups, if applicable

Number of samples

Sequencing Platform (if applicable)

Data Specifics

Where are the data being stored?

How will this data be provided to us?

Do we have your permission to access and move data for this analysis?

Was this data generated at the University of Michigan or an external institution?

Does any of this data need HIPAA-compliant storage?

Is there an IRB/MTA/DUA in place for this study? Please indicate study number

Submit   Clear

---

Interested investigators who need assistance with cancer related research should contact: